U.S. Water Utilities Stock News

NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Ziff Davis Refocuses On Core Business As RetailMeNot Bets On Cash Back

RetailMeNot, a Ziff Davis (NasdaqGS:ZD) company, has launched a Guaranteed Cash Back program that offers assured and stackable rewards for shoppers. Ziff Davis completed its exit from the Games Publishing business in Q4 2025, refocusing on its core operations. For you as an investor, these moves sit at the heart of what Ziff Davis does today: a mix of digital media, subscription based services, and advertising supported platforms. RetailMeNot’s Guaranteed Cash Back program reflects how...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol-Myers Squibb Cancer Advances Test Valuation Gap For Investors

Bristol-Myers Squibb (NYSE:BMY) and SystImmune report highly positive Phase 3 interim results for izalontamab brengitecan in advanced triple-negative breast cancer. The trial shows significant gains in progression-free survival and overall survival for patients in a hard-to-treat cancer setting. The FDA accepts the new drug application for iberdomide for multiple myeloma, granting Breakthrough Therapy Designation and Priority Review. Iberdomide is described as a first-in-class cereblon E3...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Is It Time To Reassess Viavi Solutions (VIAV) After Its Recent Share Price Surge

If you are wondering whether Viavi Solutions' share price still lines up with its fundamentals, this article will walk through what the current market price might be implying about value. At a last close of US$29.71, the stock has recent returns of 7.9% over 7 days, 41.3% over 30 days, 63.7% year to date, 165.7% over 1 year and 177.4% over 3 years, compared with 91.2% over 5 years. Recent news coverage has focused on Viavi Solutions' position within communications test and measurement and...
NYSE:AYI
NYSE:AYIElectrical

A Look At Acuity Brands (AYI) Valuation After Strong Earnings And Cautious Guidance

Acuity (AYI) is back in focus after reporting a strong quarter, with revenue up 20.2% year on year and EBITDA and adjusted operating income ahead of estimates. However, the stock has fallen since earnings. See our latest analysis for Acuity. The recent pullback, including a 17.7% 3 month share price decline and year to date share price return of negative 19.2%, contrasts with a 5 year total shareholder return of 142.2%. This suggests long term momentum while shorter term sentiment has cooled...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) Valuation Check After Sector Pullback Linked To Nvidia Earnings Reaction

What triggered the latest move in FormFactor shares FormFactor (FORM) recently dropped alongside a wider pullback in semiconductor stocks after investors sold on Nvidia’s earnings news, even though the report itself and guidance were described as strong. For you as a shareholder or watcher of the name, this kind of sector driven move raises a practical question: how much of FORM’s volatility reflects broader AI and chip sentiment versus anything specific to the company? See our latest...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Costco Tariff Refund Fight Puts Capital Allocation In New Focus

Costco Wholesale (NasdaqGS:COST) is pursuing legal action to recover tariffs paid on certain imports after the U.S. Supreme Court struck down parts of tariffs imposed during the Trump administration. The company is seeking refunds that could affect its cash position and has drawn attention to how any recovered amounts might be used, including discussion of potential special dividends. Emerging class-action lawsuits are also looking at whether consumers should share in any refunded tariffs,...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast Tests Quantum Routing While Shares Trade Below Analyst Value Estimates

Comcast (NasdaqGS:CMCSA), Classiq and AMD completed a trial using quantum and advanced classical computing for network routing resilience. The project focused on keeping Internet traffic flowing during maintenance and unexpected network issues. The trial explored quantum algorithms to support faster rerouting decisions across Comcast’s infrastructure. For you as an investor, this sits at the intersection of Comcast’s core broadband and telecom operations and emerging computing tools. As...
NYSE:EME
NYSE:EMEConstruction

EMCOR Group (EME) Is Down 10.8% After Record 2025 Results And 2026 Guidance Update – Has The Bull Case Changed?

In February 2026, EMCOR Group reported fourth-quarter 2025 sales of US$4,513.12 million and net income of US$434.61 million, contributing to full-year sales of US$16.99 billion and net income of US$1.27 billion, alongside the completion of its U.K. exit and the acquisition of Miller Electric. The company paired these record results with 2026 guidance calling for revenues of US$17.75 billion to US$18.50 billion and diluted EPS of US$27.25 to US$29.25, setting expectations for performance...
NYSE:SGHC
NYSE:SGHCHospitality

Super Group Reshapes Profile With ZAR Supercoin Tech Shift And Dividend

Super Group (NYSE:SGHC) launched the ZAR Supercoin digital payment product in South Africa, expanding beyond its core betting operations. The company received final regulatory approval for the Apricot transaction, which allows it to bring its Sportsbook technology fully in-house. Management raised the annual dividend target alongside updates on record multi regional growth and exits from the US market. Super Group, trading at $10.7, has a reported 3 year return of 196.6% and a 1 year return...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

CorMedix Expands With Melinta Buy As Valuation Gap Draws Attention

CorMedix (NasdaqGM:CRMD) has agreed to acquire Melinta Therapeutics, adding seven approved therapies to its commercial portfolio. The transaction expands CorMedix's presence in hospital and acute care settings through a broader anti infective offering. The deal marks a shift from a single product focused model toward a multi asset commercial platform. For you as an investor, CorMedix has largely been known for its focus on infection prevention products in high risk settings. By bringing...
NasdaqGS:DNUT
NasdaqGS:DNUTHospitality

Assessing Krispy Kreme (DNUT) Valuation After The New Oreo Doughnut Collection Launch

Krispy Kreme (DNUT) is back in the spotlight after expanding its collaboration with the Oreo brand, rolling out a limited time cookie themed doughnut collection that sits alongside its recent earnings release. See our latest analysis for Krispy Kreme. The Oreo collaboration and recent earnings update come after a sharp rebound in the short term, with a 7 day share price return of 23.76% and 30 day share price return of 18.67%. However, this sits against a 1 year total shareholder return...
NYSE:FLR
NYSE:FLRConstruction

The Bull Case For Fluor (FLR) Could Change Following 2025 Loss, Buybacks And NuScale Exit – Learn Why

In February 2026, Fluor Corporation reported fourth-quarter 2025 revenue of US$4,175 million with a net loss of US$1,574 million, and a full-year 2025 net loss of US$51 million, after previously reporting net income in the prior year. At the same time, Fluor completed a long-running share repurchase program totaling US$2.98 billions and is working to reshape its risk profile by exiting its majority stake in NuScale Power while maintaining a US$25.5 billions project backlog. Next, we'll...
NYSE:CIM
NYSE:CIMMortgage REITs

Is Thornburg’s Larger Stake in Chimera Investment (CIM) Altering the Institutional Case for the Stock?

On December 31, 2025, Thornburg Investment Management Inc. increased its position in Chimera Investment Corp by acquiring 250,000 additional shares, lifting its holding to more than 5.2 million shares and 6.34% of Thornburg’s total Chimera allocation. This expansion of a major institutional position highlights strengthening professional investor interest in Chimera Investment, even as the company continues to work through financial challenges. Next, we’ll examine how Thornburg’s larger...
NYSE:KBH
NYSE:KBHConsumer Durables

Assessing KB Home (KBH) After Strong Multi‑Year Share Price Gains

If you are wondering whether KB Home is priced attractively or already reflects most of its potential, this article is designed to walk you through what the numbers currently suggest about its value. The stock recently closed at US$63.58, with returns of 9.7% over the past month and 11.4% year to date, while the past 3 years show an 86.0% return and the last 5 years show 61.2%. Short term moves such as a 2.6% decline over the past week sit alongside a 6.0% return over the last year. This...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

The Bull Case For Applied Materials (AMAT) Could Change Following Sector Jitters After Nvidia Earnings And AI Forums

In the past week, Applied Materials presented at the SPIE Advanced Lithography and Patterning Conference in San Jose and at Bernstein’s “What’s Next in Tech?” forum in California, highlighting its role in AI-driven semiconductor manufacturing and investor communications. At the same time, sector-wide pressure following Nvidia’s earnings, Broadcom’s 2nm chip milestone, and continued focus on AI and advanced nodes underscored how broader semiconductor sentiment can move Applied Materials’...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Assessing Tandem Diabetes Care (TNDM) Valuation After A Strong Recent Share Price Run

Tandem Diabetes Care (TNDM) has been drawing investor attention after a strong month, with the share price returning about 32% over that period and roughly 20% in the past 3 months. See our latest analysis for Tandem Diabetes Care. Against that backdrop, Tandem Diabetes Care’s 32.4% 1 month share price return and 17.4% year to date share price return contrast with a 14.3% 1 year total shareholder return and weaker 3 and 5 year total shareholder returns. This points to momentum building...
NYSE:WSM
NYSE:WSMSpecialty Retail

Williams-Sonoma Earnings Beat Fuels Guidance Upgrade And Brand Resilience Story

Williams-Sonoma (NYSE:WSM) reported strong third quarter results, with revenue that exceeded prior expectations. Comparable sales were positive across all brands in the quarter. Management raised full year bottom line guidance and signaled increased confidence in the outlook. Williams-Sonoma, trading at $205.65, has seen very large gains over the past 3 years and 5 years, with returns above 7x over both periods. Over the past year, the stock is up 7.3%, while year to date it is up 9.5%. The...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics Five Year Briumvi Data Highlights Durable Efficacy And Valuation Gap

TG Therapeutics published five year follow up data from the Phase 3 ULTIMATE I & II studies of BRIUMVI in relapsing forms of multiple sclerosis. The JAMA Neurology paper reports durable clinical efficacy, low relapse rates, and a consistent safety and tolerability profile over the long term. The new data add long horizon evidence for BRIUMVI at a time when the multiple sclerosis treatment market remains highly competitive. TG Therapeutics, trading as NasdaqCM:TGTX, now has five year...
NYSE:IQV
NYSE:IQVLife Sciences

Is IQVIA Holdings (IQV) Pricing Reflect Recent Share Weakness And Cash Flow Outlook Accurately

If you are wondering whether IQVIA Holdings is giving you good value at around US$178.81 per share, this article will help you frame that question with hard numbers rather than headlines. The stock has moved 8.0% over the last 7 days, while returns over 30 days, year to date, 1 year and 3 years sit at 25.4% decline, 20.7% decline, 5.3% decline and 19.0% decline respectively. These price moves sit against a backdrop of ongoing interest in IQVIA's role in contract research, data and technology...
NYSE:RHLD
NYSE:RHLDProfessional Services

A Look At Resolute Holdings Management (RHLD) Valuation After Strong 1-Year Returns And Recent Share Price Weakness

Recent price moves set the stage Resolute Holdings Management (RHLD) has drawn attention after a recent stretch of weaker trading, with the share price down about 10% over the past week and 17% over the past month. See our latest analysis for Resolute Holdings Management. Those short term share price declines sit against a very different longer term picture, with the 1 year total shareholder return around 260%, suggesting earlier buyers have still seen very strong gains despite fading recent...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Guardant Health Acquisition Spurs Inducement Grants And Draws Investor Attention

Guardant Health (NasdaqGS:GH) granted significant inducement equity awards to new employees under its 2023 Employment Inducement Incentive Award Plan following the acquisition of a competitor. The company’s role as a key performance contributor was recently highlighted by the Aristotle Growth Equity Fund, which pointed to the acquisition and robust revenue growth as important drivers. These developments reflect material changes in Guardant Health’s team structure and market positioning that...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Intuit (INTU) Margin Expansion Tests Bearish Spending Narratives After Q2 2026 Results

Intuit (INTU) has put solid numbers on the board for Q2 2026, with revenue of US$4.7b, basic EPS of US$2.48 and net income of US$693m, backed by trailing 12 month EPS of US$15.53 on revenue of US$20.1b. The company has seen quarterly revenue shift from US$3.9b in Q2 2025 to US$4.7b in Q2 2026, while basic EPS moved from US$1.68 to US$2.48 over the same period. This sets the context for trailing earnings growth of 42.9% and a net margin of 21.6%. For investors, the combination of higher recent...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly’s AI Edge Pivot Links New Profitability With Rising Security Stakes

Fastly (NasdaqGS:FSLY) has emerged as a key player in AI and edge computing, highlighting its role in supporting AI-first applications at the network edge. The company has reached a new profitability milestone after a history of losses, signaling a shift in how its edge cloud platform is being used and monetized. Fastly released a new Global Security Research Report that focuses on cyber risks facing AI-first businesses, calling out rising threats around data integrity, model abuse, and edge...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Enovis Weighs US$501.3m Impairment Against Nebula Led Organic Growth

Enovis (NYSE:ENOV) recorded a goodwill impairment charge of over $500 million in Q4 2025, tied to changes in its business mix and accounting assumptions. The company reported strong organic growth in key segments in the same period, supported by new product launches. Recently introduced products, including the Nebula Stem and OrthoDrive Impactor, are gaining traction, with Nebula competing directly against established peers. For investors tracking Enovis, the combination of a large goodwill...